Inhibiting Effects of Hwallak-dan(Huoluo-dan) on the Adjuvant-induced Arthritis in Lewis Rats

활락단(活絡丹)의 Adjuvant 유발 관절염 진행 억제 효과

  • Kim, Deok-Hee (Dept. of Oriental Rehabilitation Medicine, College of Oriental Medicine, Se-Myung University) ;
  • Jeong, Su-Hyeon (Dept. of Oriental Rehabilitation Medicine, College of Oriental Medicine, Se-Myung University) ;
  • Seo, Il-Bok (Dept. of Anatomy, College of Oriental Medicine, Se-Myung University) ;
  • Kim, Soon-Joong (Dept. of Oriental Rehabilitation Medicine, College of Oriental Medicine, Se-Myung University)
  • 김덕희 (세명대학교 한의과대학 한방재활의학과교실) ;
  • 정수현 (세명대학교 한의과대학 한방재활의학과교실) ;
  • 서일복 (세명대학교 한의과대학 해부학교실) ;
  • 김순중 (세명대학교 한의과대학 한방재활의학과교실)
  • Received : 2010.12.13
  • Accepted : 2011.01.04
  • Published : 2011.01.30

Abstract

Objectives : This study was to investigate the antiarthritic effect of Hwallak-dan(Huoluo-dan) on the complete freund's adjuvant(CFA)-induced arthritis in Lewis rats. Methods : Arthritis was induced by intradermal injection of CFA into base of tail. Experimental groups divided into normal(n=10), control(n=10) and treated(n=10) group. Animals of control group received normal saline for twenty days, treated group received extracts Hwallak-dan(Huoluo-dan) for same duration, light mineral oil only injected non-arthritic rats were served as normal group. The incidence of arthritis and arthritic index were observed after treatment. Body weight, paw edema volume and thickness of ankle joint were measured at 0, 11, 14, 17, 20 days after treatment. White blood cell(WBC) counts in blood were analysed at 20 days after treatment and tumor necrosis $factor-{\alpha}(TNF-{\alpha})$, $interleukin-1{\beta}(IL-1{\beta}$), IL-6 contents in paw exudate were analysed by ELISA at 20 days after treatment. Histopathology on the ankle joint were performed at 20 days after treatment. Results : 1. Incidence of arthritis of treated group was 60% and control group was 100% at 20 days after treatment. 2. Arthritic index of treated group was significantly decreased compared with control group at 20 days after treatment. 3. Paw edema volume and thickness of ankle joint of treated group was significantly decreased compared with control group at 20 days after treatment. 4. Total WBC of treated group was significantly decreased compared with control group at 20 days after treatment. 5. Neutrophils of treated group was significantly decreased compared with control group at 20 days after treatment. 6. $TNF-{\alpha}$ content in paw exudate of treated group was significantly decreased compared with control group at 20 days after treatment. 7. $IL-1{\beta}$ content content in paw exudate of treated group was significantly decreased compared with control group at 20 days after treatment. 8. IL-6 content content in paw exudate of treated group was significantly decreased compared with control group at 20 days after treatment. 9. Histopathological arthritic index of treated group was significantly decreased compared with control group at 20 days after treatment. Conclusions : These results indicate that Hwallak-dan(Huoluo-dan) has inhibitory effect on the development and progression of CFA-induced arthritis in rats.

Keywords

Hwallak-dan(Huoluo-dan);Adjuvant arthritis;WBC;$TNF-{\alpha}$;$IL-1{\beta}$;IL-6

Acknowledgement

Supported by : 지식경제부

References

  1. 송영욱. 최근 조명된 류마티스 관절염의 병태 생리. 대한내과학회지. 2009;76(1):1-6.
  2. Holborow EJ. The relationship of autoimmunity to rheumatoid arthritis. Proc R Soc Med. 1964;57:59-62.
  3. Lee DM, Weinblatt ME. Rheumatiod arthritis. Lancet. 2001;358:903-11. https://doi.org/10.1016/S0140-6736(01)06075-5
  4. Smolen JS, Aletaha D, Koeller M, Weisman MH, Emery P. New therapies for treatment of rheumatoid arthritis. Lancet. 2007;370(9602):1861-74. https://doi.org/10.1016/S0140-6736(07)60784-3
  5. Pisetsky DS, St Clair EW. Progress in the treatment of rheumatoid arthritis. JAMA. 2001;286(22):2787-90. https://doi.org/10.1001/jama.286.22.2787
  6. Lard LR, Visser H, Speyer I, vander Horst-Bruinsma IE, Zwinderman AH, Breedveld FC, Hazes JMW. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med. 2001;111(6):446-51. https://doi.org/10.1016/S0002-9343(01)00872-5
  7. 한방재활의학과학회. 한방재활의학. 서울:군자출판사. 2005:96-7.
  8. 陳師文. 太平惠民和劑局方. 北京:旋風出版社. 1975:14.
  9. 허준. 국역증보동의보감. 서울:남산당. 1998:534.
  10. 강승범, 박종운, 김종길, 조남수, 문병순. 활락단이 항염, 진통 및 항혈전에 미치는 영향에 대한 연구. 대한한방내과학회지. 1999;20(1):57-72.
  11. Pearson CM. Development of arthritis, periarthritis and periostitis in rats given adjuvant. Proc Soc Exp BioI Med. 1956:15, 95-101.
  12. Brahm E. Animal models of rheumatoid arthritis. Clues to etiology and treatment. Clin Orthop. 1991;265:42-53.
  13. 張紹元. 生藥에 의한 adjuvant 관절염의 억제. 生藥學會誌. 1982;36:78-81.
  14. 선민식, 이종수. 防風湯이 adjuvant 유발관절염에 미치는 영향. 동의물리요법과학회지. 1994;4(1):135-46.
  15. 김순중, 이철완. 三氣飮 및 三氣飮去附子가 adjuvant 관절염 유발시 활성산소에 미치는 영향. 한방재활의학과학회지. 1997;7(2):1-45.
  16. 서해경, 오민석, 송태원. 獨活寄生湯加猫脛骨이 adjuvant 關節炎에 미치는 影響. 한방재활의학과학회지. 2001;11(2):111-24.
  17. 조윤형, 임형호. 天授根이 adjuvant 유발관절염에 미치는 영향. 한방재활의학과학회지. 2002;12(2):175-86.
  18. 김근찬, 이명종. 羌活續斷湯이 adjuvant 유발관절염 동물 model에 미치는 영향. 한방재활의학과학회지. 2004;14(1):1-18.
  19. 설재욱, 신미선, 최진봉. 麻黃羌活湯이 adjuvant 관절염에 미치는 실험적 효과. 한방재활의학과학회지. 2005;15(2):55-65.
  20. 손동우, 서일복, 김순중. 珍痛散이 흰쥐의 adjuvant 유발 관절염 및 척수 내 c-fos 발현에 미치는 영향. 한방재활의학과학회지. 2005;15(3):25-43.
  21. Pincus T, Callahan LF. What is the natural history of rheumatoid arthritis? Rheumatic diseases clinics of North America. 1993;19(1):123-51.
  22. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, Spitz PW, Haga M, Kleinheksel SM, Cathey MA. The mortality of rheumatoid arthritis. Arthritis and rheumatism. 1994;37(4):481-94. https://doi.org/10.1002/art.1780370408
  23. Gay S, Koopman WJ. Immunopathology of rheumatoid arthritis. Current opinion in rheumatology. 1989;1(1):8-14. https://doi.org/10.1097/00002281-198901010-00004
  24. Klareskog L, Johnell O, Hulth A, Holmdahl R, Rubin K. Reactivity of monoclonal anti-type II collagen antibodies with cartilage and synovial tissue in rheumatoid arthritis and osteoarthritis. Arthritis and rheumatism. 1986;29(6):730-8. https://doi.org/10.1002/art.1780290605
  25. Hart PH, Vitti GF, Burgess DR, Whitty GA, Piccoli DS, Hamilton JA. Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor-${alpha}$, interleukin 1, and prostaglandin $E_2$. PNAS. 1989;86(10):3803-7. https://doi.org/10.1073/pnas.86.10.3803
  26. Angel J, Colard O, Chevy F, Fournier C. Interleukin-1-mediated phospholipid breakdown and arachidonic acid release in human synovial cells. Arthritis and rheumatism. 1993;36(2):158-67. https://doi.org/10.1002/art.1780360205
  27. McDonnell J, Hoerrner LA, Lark MW, Harper C, Dey T, Lobner J, Eiermann G, Kazazis D, Singer II, Moore VL. Recombinant human interleukin-1${\beta}$-induced increase in levels of proteoglycans, stromelysin and leukocytes in rabbit synovial fluid. Arthritis and rheumatism. 1992;35(7):799-805. https://doi.org/10.1002/art.1780350714
  28. 해리슨내과학편찬위원회. HARRISON'S 내과학. 서울:도서출판정담. 1997:179, 242-3, 465-9, 1777-85.
  29. Houssiau FA, Devogelaer JP, Van Damme J, de Deuxchaisnes CN, Van Snick J. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis and rheumatism 1988;31(6):784-8. https://doi.org/10.1002/art.1780310614
  30. Manicourt DH, Triki R, Fukuda K, Devogelaer JP, Nagant de Deuxchaisnes C, Thonar EJ. Levels of circulating tumor necrosis factor ${\alpha}$ and interleukin-6 in patients with rheumatoid arthritis. Relationship to serum levels of hyaluronan and antigenic keratan sulfate. Arthritis and rheumatism. 1993;36(4):490-9. https://doi.org/10.1002/art.1780360409
  31. 양유걸. 黃帝內經素問譯解. 서울:일중사. 1991:328.
  32. 華陀. 華陀中藏經. 北京:自由出版社. 1994:31-3, 50-2.
  33. 劉完素. 金元四大家醫學全書(河間六書). 天津:天津科學技術出版社. 1992:54-5.
  34. 吳謙. 醫宗金鑑. 서울:大星文化社. 1994:352, 503-4.
  35. 張仲景. 金櫃要略方論. 臺北:大聯國風出版社. 1973:32-3.
  36. 張介賓. 景岳全書. 서울:杏林書院. 1975:153-9.
  37. 權宰植. 痺證. 서울:鼎談出版社. 1993:23-9, 151-75, 207-8, 214-5, 219-22, 270.
  38. 강인수. 痺證治療의 用藥에 關한 小考. 대한한의학회지. 1990;11(1):245-52.
  39. 張鐵軍. 抗風濕中草彩色圖譜. 北京:중국중의약출판사. 1997:1.
  40. 이중휘, 송태원, 오민석. "方藥合編"에 수록된 비중처방에 대한 연구. 대전대한의학연구소논문집. 2001;10(1):375-83.
  41. 이상인. 본초학. 서울:수서원. 1981:321, 346, 444, 446, 551.
  42. Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen an experimental model of arthritis. The journal of experimental medicine. 1977;146(3):857-68. https://doi.org/10.1084/jem.146.3.857
  43. Noyori K, Okamoto R, Takagi T, Hyodo A, Suzuki K, Koshino T. Experimental induction of arthritis in rats immunized with Escherichia coli 0:14 lipopolysaccharide. The journal of rheumatology. 1994;21(3):484-8.
  44. Saso Y, Conner EM, Teegarden BR, Yuan CS. S-Adenosyl-L-homocysteine hydrolase inhibitor mediates immunosuppressive effects in vivo: suppression of delayed type hypersensitivity ear swelling and peptidoglycan polysaccharide-induced arthritis. The journal of pharmacology and experimental therapeutics. 2001;296(1):106-12.
  45. Soballe K, Pedersen CM, Odgaard A, Juhl GI, Hansen ES, Rasmussen HB, HvussI, Bunger C. Physical bone changes in carragheenin-induced arthritis bos iated by quantitative computed tomography. Skeletal radiology. 1991;20(5):345-52. https://doi.org/10.1007/BF01267662
  46. Karman K, Ortmann RA, Kimpel D. Animal models of rheumatoid arthritis and their relevance to human disease. Pathophysiology. 2005;12(3):167-81. https://doi.org/10.1016/j.pathophys.2005.07.011
  47. Bendele A, McComb J, Gould T, McAbee T, Sennello G, Chlipala E, Guy M. Animal models of arthritis: relevance to human disease. Toxicologic pathology. 1999;27(1):134-42. https://doi.org/10.1177/019262339902700125
  48. 서영석. 활락단전탕액이 척수운동신경세포에 미치는 영향. 원광대학교대학원. 1999.
  49. 송왕기, 권강범, 이호승, 김희찬, 김우경, 오광수, 안효창, 류도곤. 활락단 전탕액이 Hydrogen Peroxide에 의해 손상된 배양척수감각신경세포의 LDH활성도에 미치는 효과. 동의병리학회지. 2001;15(3):464-8.
  50. Taurog JD, Argentieri DC, McReynolds RA. Adjuvant arthritis. Methods in enzymology. 1988;162:339-55.
  51. 이귀녕, 이종순. 임상병리파일. 서울:의학문화사. 1993:82-3, 86-7, 740-1, 850-2, 1035-7, 1383-4.
  52. 대한병리학회. 병리학. 서울:고문사. 1995:71-103, 166, 960-2, 1165-70.
  53. 정태호, 김정철, 김문규. 최신면역강의. 대구:경북대학교출판부. 1996:10, 22, 25, 77, 193, 200, 211-2, 215, 232-5, 248, 357.
  54. 황상익. 면역의 의미론. 서울:하늘과학문고. 1998:43, 45, 69, 92.
  55. Wood NC, Dickens E, Symons JA, Duff GW. In situ hybridization of interleukin-1 in CD14-positive cells in rheumatoid arthritis. Clinical immunology and immunopathology. 1992;62(3):295-300. https://doi.org/10.1016/0090-1229(92)90106-X
  56. Chu CQ, Field M, Feldmann M, Maini RN. Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis and rheumatism. 1991;34(9):1125-32. https://doi.org/10.1002/art.1780340908
  57. 서울대학교의과대학. 면역학. 서울:서울대학교 출판부. 1997:100, 114, 117, 253, 255, 262.
  58. Yaron I, Meyer FA, Dayer JM, Yaron M. Human recombinant interleukin-1 ber stimulates glycosaminoglycan production in human synovial fibroblast cultures. Arthritis and rheumatism. 1987;30(4):424-30. https://doi.org/10.1002/art.1780300410
  59. Janeway CA, Travers P. Immunobiology: the immune system in health and disease. New York:Garland Pub. 1997:8-10, 14.
  60. Okamoto H, Yamamura M, Morita Y, Harada S, Makino H, Ota Z. The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor and oncostatin M in rheumatoid arthritis. Arthritis and rheumatism. 1997;40(6):1096-105. https://doi.org/10.1002/art.1780400614
  61. Leisten JC, Gaarde WA, Scholz W. Interleukin-6 serum levels correlate with footpad swelling in adjuvant-induced arthritic lewis rats treated with cyclosporin A or indomethacin. Clinical immunology and immunopathology. 1990; 56(1):108-15. https://doi.org/10.1016/0090-1229(90)90174-O
  62. Conforti A, Lussignoli S, Bertani S, Verlato G, Ortolani R, Bellavite P, Andrighetto G. Specific and long-lasting suppression of rat adjuvant arthritis by low-dose mycobacterium butyricum. European journal of pharmacology. 1997;324(2):241-7. https://doi.org/10.1016/S0014-2999(97)00068-X
  63. 대한정형외과학회. 정형외과학. 서울:최신의학사. 1988:55-6, 109-18, 121-33, 176.